ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2782

Autoantibodies from Single Circulating Plasmablasts React with Citrullinated Antigens and Porphyromonas Gingivalis in Rheumatoid Arthritis

Song Li1, Yangsheng Yu1, Yinshi Yue1, Hongyan Liao1, Wanqin Xie1, Jessica Thai1, Ted R. Mikuls2, Geoffrey M. Thiele3, Michael J. Duryee4, Jeffrey Payne5, Lynell W. Klassen6, James R. O'Dell7, Zhixin Zhang8 and Kaihong Su1, 1Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, 2Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 3Internal Medicine, Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 4Internal Medicine Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 5College of Dentistry, University of Nebraska Medical Center, Lincoln, NE, 6Dept of Internal Medicine, Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 7Veteran Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 8Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Anti-citrullinated protein/peptide antibodies (ACPA) and rheumatoid arthritis (RA), P. Gingivalis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: ACR Plenary Session III: Discovery 2014

Session Type: Plenary Sessions

Background/Purpose

Anti-citrullinated protein antibodies (ACPAs) are highly specific for rheumatoid arthritis (RA) and also believed to play a pathogenic role in RA. Porphyromonas gingivalis (P. gingivalis), a Gram negative oral pathogen associated with periodontitis, has long been speculated as a trigger for the anti-citrulline autoimmune responses in RA patients. However, the detail relation between ACPA and P. gingivalis is still unclear.

Methods

In this study, we made 195 recombinant monoclonal antibodies from anti-cyclic citrullinated peptide (CCP)-positive RA patients (N=6), 23 recombinant monoclonal antibodies from CCP-negative RA patients (N=1), and 110 recombinant monoclonal antibodies from healthy controls (N=4) using a single cell-based antibody cloning approach. All the 7 RA patients satisfied the 2010 ACR classification criteria. Monoclonal ACPAs were determined by commercial anti-CCP test and fine specificity with 3 synthesized citrullinated peptides. Cross-reactivity of ACPA to P. gingivalis was tested by ELISA against P. gingivalis outer membrane protein and citrullinated peptide from P. gingivalis enolase. Immunoglobulin genes of 5 ACPAs were reverted to the germ line sequences and the corresponding antibodies were also expressed for the above tests.

Results

The relative frequencies of circulating plasmablasts were significantly higher in RA patients than in healthy donors ( p = 0.0015). About 19.5% of circulating plasmablast-derived recombinant antibodies from CCP-positive RA patients, but none from the CCP-negative RA patient or healthy donors, specifically recognized citrullinated RA autoantigens ( p = 0.0001). The immunoglobulin genes encoding these ACPAs were highly mutated with increased replacement/silent mutation ratios, suggesting that the generation of ACPAs involved active antigen selection. Interestingly, 63% of these ACPAs cross-reacted with the outer membrane antigens and/or citrullinated enolase from P. gingivalis. Germ-line reversions of some ACPAs completely eliminated their reactivity to citrullinated RA autoantigens but retained their reactivity to P. gingivalis antigens.

Conclusion

These results suggest that circulating plasmablasts in RA patients produce ACPAs and this process may be, in part, initiated by the anti-P. gingivalis immune responses.


Disclosure:

S. Li,
None;

Y. Yu,
None;

Y. Yue,
None;

H. Liao,
None;

W. Xie,
None;

J. Thai,
None;

T. R. Mikuls,
None;

G. M. Thiele,
None;

M. J. Duryee,
None;

J. Payne,
None;

L. W. Klassen,
None;

J. R. O’Dell,
None;

Z. Zhang,
None;

K. Su,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/autoantibodies-from-single-circulating-plasmablasts-react-with-citrullinated-antigens-and-porphyromonas-gingivalis-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology